Rite Aid Stock Price


-0.0005 (-0.01%)
Volume 4,192
Bid Price
Ask Price
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Rite Aid Corp RAD NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0005 -0.01% 3.4495 08:50:03
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
11 4,192 - 3.17 - 11.605
Last Trade Time Type Quantity Stock Price Currency
08:50:03 formt 1,000 $ 3.4495 USD


Draw Mode:

Rite Aid Corp Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 194.98M 56.52M 48.64M $ 24.57B $ -906.57M -9.96 -0.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 34.00%

more financials information »

Rite Aid News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RAD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.2253.623.173.392,393,4950.22456.96%
1 Month3.263.8553.173.402,633,2490.18955.81%
3 Months5.337.373.174.262,528,130-1.88-35.28%
6 Months7.6611.6053.175.652,607,059-4.21-54.97%
1 Year10.2511.6053.176.752,975,867-6.80-66.35%
3 Years11.9632.483.1712.693,171,474-8.51-71.16%
5 Years44.4046.003.1721.066,321,356-40.95-92.23%

Rite Aid Description

Rite Aid Corp is a large retail drugstore chain in the United States. The company reports via two segments: retail pharmacy and pharmacy services. The retail pharmacy segment generates revenue primarily through the sale of prescription drugs, along with an assortment of merchandise that includes over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and numerous other everyday consumables. The pharmacy-services segment relates to EnvisionRx, a fully owned subsidiary that operates as a pharmacy benefit management provider offering a broad range of pharmaceutical services.